UMontréal IRCM receives $31M investment to accelerate biomedical research

The Institut de recherches cliniques de Montréal (IRCM) has received a $31M investment from the Government of Quebec. The IRCM, which is affiliated with the Université de Montréal, will use the investment to support its research and clinical activities until 2023-2024. The funding will allow scientists and clinicians to accelerate their biomedical research to support the population of QC and beyond. “While the importance of advancing knowledge [and] care techniques has shown its relevance, these sums will allow our researchers, our clinicians, and all their teams to continue their work on all fronts,” said IRCM Interim President Dr Jean-François Côté. IRCM| Journal de Montréal Note: Archived stories may contain dead links or be missing source links.